# Glenmark Pharmaceuticals Inc  USA – FDA Inspection, Jul 26, 2019

Source: https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-inc-usa/1590af97-9645-4c46-b18b-24ab434e394f
Source feed: FDA_Inspections

> FDA inspection 1097806 of Glenmark Pharmaceuticals Inc  USA, July 26, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1097806
- Company Name: Glenmark Pharmaceuticals Inc  USA
- Inspection Date: 2019-07-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Atlanta District Office
- Citation Count: 1

## Related Documents

- [FDA Inspection 1267093 - 2025-06-17](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-inc-usa/3ab7d010-f073-47f9-8788-ab4b11e320be)
- [FDA Inspection 1169876 - 2022-05-19](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-inc-usa/c6d894dc-2cf7-4a92-a7a4-e3bc286496af)
- [FDA Inspection 1052635 - 2018-05-18](https://www.keypedia.com/records/fda_inspections/glenmark-pharmaceuticals-inc-usa/51543d47-6df2-4fe4-897e-2dd19b3aca7a)

## Related Officers

- [Seneca D. Toms](https://www.keypedia.com/people/seneca-d-toms/3eda62a2-4c12-438f-805a-5e3efb0f2f94)

Company: https://www.keypedia.com/companies/glenmark-pharmaceuticals-inc-usa/83c18d68-8e9d-454a-a365-3fe29c7d3e31

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7
